Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population

Medicina Clinica

Volumn 117, Issue 14, 2001, Pages 530-533

  Ascaso, Juan F ^a   Real, José T ^a   Priego, Antonia ^a   Carmena, Rafael ^a   Romero, Pedro ^a   Valdecabres, Carmen ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Fasting plasma insulin values; HOMA index; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CALCULATION; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC DISORDER; OUTPATIENT CARE; PARAMETER; PATIENT SELECTION; POPULATION; RANDOMIZATION; SPAIN; STANDARD; STATISTICAL MODEL; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; RISK;

ADULT; AGED; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; ODDS RATIO;

EID: 0035802774     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(01)72168-9     Document Type: Article

References (30)

1. Syndrome X: 6 years later
2. The Metabolic Syndrome: Roots, myths, and facts
3. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
4. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration
5. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten year later
6. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: Results from the 11 year follow-up of the Paris Prospective Study
7. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men
8. The metabolically obese, normal weight individual revisated
9. A study of insulin resistance, using the minimal model, in non-diabetic familial combined hyperlipidemic patients
10. Alteración de la secreción de insulina en la hiperlipemia familiar combinada
11. Practical statistics for medical research
12. Técnicas de muestreo
13. Muestreo para la investigación en ciencias de la salud
14. Enzymatic determination of total serum cholesterol
15. Influence of free glycerol on enzymatic of triglycerides
16. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
17. Some considerations of methodology and standardization of apolipoprotein B immunoassays
18. Enzymatic colorimetric method for glucose determination
19. Quantitative aspects of the reaction between insulin and insulin-binding antibody
20. Homeostasis model assessment: Insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man
21. Insulin sensitivity and its measurement: Structural commonalities among the methods
22. Estadística multivariante en las ciencias de la vida
23. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp
24. Glucose clamp technique. A method for quantifying insulin secretion and resistance
25. Assessment of insulin sensitivity in vivo
26. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity
27. A prospective analysis of the HOMA model
28. Insulin levels during fasting and the glucose tolerance test and HOMA’s index predict subsequent development of hypertension
29. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance. A prospective study in Mauritius
30. Resistencia a la insulina y síndrome metabólico en familiares de primer grado de pacientes con diabetes tipo 2